# FDA Inspection 1257822 - Hangzhou ApexTide Biomedical Technology Co., Ltd. - November 01, 2024

Source: https://www.keypedia.com/records/fda_inspections/hangzhou-apextide-biomedical-technology-co-ltd/7b651bda-6ba1-43ba-b084-c7403b3b2732
Source feed: FDA_Inspections

> FDA Inspection 1257822 for Hangzhou ApexTide Biomedical Technology Co., Ltd. on November 01, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257822
- Company Name: Hangzhou ApexTide Biomedical Technology Co., Ltd.
- Inspection Date: 2024-11-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1257822 - 2024-11-01](https://www.keypedia.com/records/fda_inspections/hangzhou-apextide-biomedical-technology-co-ltd/1f4170ae-7da3-4ab6-8961-a48db09ad058)

Company: https://www.keypedia.com/companies/hangzhou-apextide-biomedical-technology-co-ltd/0bdf8f05-4699-4044-9bc2-13608fdf3953

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c